The Global Flunixin Meglumine API Market was valued at US$ 85 million in 2024 and is projected to reach US$ 115 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period (2024–2030). This growth is driven by increasing livestock healthcare needs, rising demand for veterinary NSAIDs, and expanding applications in equine and bovine medicine.
As the veterinary pharmaceutical sector evolves to meet global animal health demands, focus shifts to API manufacturers producing high-purity Flunixin Meglumine. This analysis examines the Top 10 Companies in the Flunixin Meglumine API Industry—a strategic mix of specialty chemical producers, pharmaceutical innovators, and veterinary-focused API suppliers shaping quality standards.
🔟 1. Rochem International Inc
Headquarters: New York, USA
Key Offering: USP-grade Flunixin Meglumine API
Rochem International maintains FDA-approved facilities producing cGMP-compliant Flunixin Meglumine. The company specializes in high-potency veterinary APIs with ultra-low impurity profiles.
Quality Certifications:
- FDA and EMA regulatory filings
- ISO 9001:2015 certified production
- Validated analytical methods (HPLC/GC)
Download FREE Sample Report: Global Flunixin Meglumine API Market – View in Detailed Research Report
9️⃣ 2. Ashland Global Holdings
Headquarters: Wilmington, Delaware, USA
Key Offering: Flunixin Meglumine for veterinary formulations
Ashland’s pharmaceutical division supplies GMP-certified Flunixin Meglumine to leading animal health companies worldwide, supporting injectable and oral dosage forms.
Quality Certifications:
- USP/EP/JP compliance
- Dedicated veterinary API production lines
- Controlled substance handling capabilities
8️⃣ 3. Excella GmbH
Headquarters: Feucht, Germany
Key Offering: European Pharmacopoeia Flunixin Meglumine
Excella specializes in veterinary NSAID APIs, supplying EU markets through its optimized production facility featuring advanced purification technologies.
Quality Certifications:
- EDQM CEP certification
- REACH and TSCA compliance
- Custom particle engineering services
7️⃣ 4. Cayman Chemical Company
Headquarters: Ann Arbor, Michigan, USA
Key Offering: Research-grade Flunixin Meglumine
Cayman provides analytical reference standards and small-batch API manufacturing for veterinary drug development and pharmacokinetic studies.
Quality Certifications:
- ISO/IEC 17025 accredited
- Stability-indicating methods
- COA with full traceability
Download FREE Sample Report: Global Flunixin Meglumine API Market – View in Detailed Research Report
6️⃣ 5. NGL Fine-Chem Ltd
Headquarters: Mumbai, India
Key Offering: Cost-competitive Flunixin Meglumine API
This Indian API manufacturer operates WHO-GMP certified facilities producing Flunixin Meglumine at commercial scale for global veterinary markets.
Quality Certifications:
- WHO-GMP compliance
- Multiple FDA inspections
- Continuous process optimization
5️⃣ 6. Zhejiang Hisoar Pharmaceutical
Headquarters: Hangzhou, China
Key Offering: Flunixin Meglumine for Asian markets
As China’s veterinary API production expands, Zhejiang Hisoar emerges as a quality-focused supplier serving domestic and international formulation partners.
Quality Certifications:
- China GMP certification
- EXCiPACT certified
- Cost-efficient scale production
4️⃣ 7. Shandong Lukang Pharmaceutical
Headquarters: Jining, China
Key Offering: Large-scale Flunixin Meglumine production
Shandong Lukang operates one of Asia’s largest veterinary API facilities, supplying pharmaceutical companies worldwide with consistent quality Flunixin Meglumine.
Quality Certifications:
- FDA and EU GMP compliance
- Automated production systems
- Continuous crystallization technology
3️⃣ 8. Hubei Longxiang Pharmaceutical
Headquarters: Wuhan, China
Key Offering: Veterinary-grade Flunixin Meglumine API
Specializing in animal health APIs, Hubei Longxiang exports Flunixin Meglumine to emerging markets with growing livestock sectors.
Quality Certifications:
- Multiple pharmacopeia compliance
- Metal impurity controls
- Custom manufacturing options
2️⃣ 9. Qilu Synva Pharmaceutical
Headquarters: Jinan, China
Key Offering: Flunixin Meglumine and intermediates
Qilu Synva integrates API synthesis with advanced purification to deliver high-purity Flunixin Meglumine for veterinary applications.
Quality Certifications:
- Vertically integrated production
- Process validation expertise
- Technical transfer capabilities
Get Full Report Here: Global Flunixin Meglumine API Market – View in Detailed Research Report
1️⃣ 10. Hangzhou Dayangchem
Headquarters: Hangzhou, China
Key Offering: R&D quantities of Flunixin Meglumine
Hangzhou Dayangchem serves research institutions and specialty pharmaceutical developers with small-batch, high-purity API for formulation studies.
Quality Certifications:
- Custom synthesis services
- Analytical method development
- Stability study support
🌍 Market Outlook: Veterinary API Sector Growth Through 2030
The Flunixin Meglumine API market demonstrates steady expansion as livestock producers worldwide increase adoption of veterinary NSAIDs. Beyond traditional applications, new formulations and therapeutic combinations present significant growth opportunities.
📈 Key Industry Trends:
- Stricter global regulatory standards for veterinary APIs
- Rising demand in Asia-Pacific livestock markets
- Development of combination therapies with antibiotics
- Expansion into companion animal medicine
Get Full Report Here: Global Flunixin Meglumine API Market – View in Detailed Research Report
The featured companies are not merely supplying APIs—they’re driving quality innovation in veterinary pharmaceuticals through technical expertise and compliance leadership.
